Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of infection

Background and Aim: Inhibition of gastric acid secretion is important for eradicating Helicobacter pylori . Vonoprazan (VPZ) is a strong, long-lasting inhibitor of gastric acid secretion. Studies that examined the effectiveness of VPZ-based triple therapy in second-line treatment have been performed...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mariko Hojo, Daisuke Asaoka, Tsutomu Takeda, Yuji Shimada, Kenshi Matsumoto, Kohei Matsumoto, Noboru Yatagai, Yoichi Akazawa, Kumiko Ueda, Hiroya Ueyama, Akihito Nagahara
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2020-11-01
coleção:	Therapeutic Advances in Gastroenterology
Acesso em linha:	https://doi.org/10.1177/1756284820966247
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!